Biocon Limited has published newspaper advertisements on April 28, 2026, as part of the Second 100 Days Campaign 'Saksham Niveshak' launched by the Investor Education and Protection Fund Authority (IEPF), Ministry of Corporate Affairs, Government of India. The company has submitted copies of these advertisements to stock exchanges under regulatory compliance requirements.

Campaign Background and Objective

The Second 100 Days Campaign 'Saksham Niveshak' is a continuation of an earlier initiative launched by the IEPF Authority through its circular dated July 16, 2025. The campaign requests companies to reach out to shareholders whose dividends remain unpaid/unclaimed before they get transferred to the Investor Education and Protection Fund.

Regulatory Compliance and Publication Details

Biocon Limited has fulfilled its regulatory obligations by publishing the advertisements and notifying the stock exchanges. The company submitted the advertisement copies to both BSE Limited and National Stock Exchange of India Limited pursuant to Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Shareholder Action Requirements

The advertisements outline specific actions required from shareholders to claim their unpaid/unclaimed dividends:

For shareholders holding shares in physical mode:

• As prescribed by SEBI, effective April 01, 2024, shareholders with physical shares and outdated KYC details are eligible for dividend only in electronic mode
• Required details include: PAN, Contact Details, and Signature
• Shareholders must submit Investor Service Request (ISR) Forms ISR-1 and ISR-2 to the company's Registrar and Transfer Agent

For shareholders holding shares in demat form:

• Shareholders can claim dividends by updating bank details with their respective Depository Participants
• Updates will automatically appear in the company's subsequent records

Contact Information and Support

Shareholders requiring assistance can contact the company or its Registrar and Transfer Agent. The company has provided comprehensive contact details for shareholders to update their information and claim unpaid dividends.

The information and detailed guidelines are also available on the company's website at www.biocon.com for shareholder reference and action.

Biocon Limited has formally notified the stock exchanges about its board meeting scheduled for May 07, 2026, to approve financial results for the fourth quarter and full financial year 2025-26. The company filed the intimation under Regulation 29(1) of SEBI Listing Obligations and Disclosure Requirements Regulations, 2015.

Board Meeting Details

The Board of Directors meeting is scheduled to take place on Thursday, May 07, 2026. The primary agenda includes approval and recording of audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026, along with dividend recommendation considerations.

Trading Window Restrictions

In compliance with insider trading regulations, Biocon has implemented a trading window closure for company securities. The restrictions are in effect from Wednesday, April 01, 2026 to Saturday, May 09, 2026, both days inclusive, as per the company's Code of Conduct for Prevention of Insider Trading.

Earnings Conference Call

Biocon will conduct an earnings conference call for analysts and investors following the board meeting. The call is scheduled for Friday, May 08, 2026 at 09:00 hrs IST and will be conducted via Zoom platform.

Recording and Documentation

The company will provide comprehensive documentation of the earnings call with specific timelines for availability:

The investor relations contact for further information is Prashant Nair, who can be reached at +91 6775 1714 or +91 98200 95476, or via email at prashant.nair@biocon.com . The official communication was signed by Rajesh U. Shanoy, Company Secretary and Compliance Officer, and filed with both BSE and NSE on April 23, 2026.